Max Robotics — Global Service Robot Directory + US Certification

About

Palanisamy Senthilnathan is a pioneering hepatopancreatobiliary (HPB) surgeon whose work has fundamentally shaped the global adoption of minimally invasive pancreas surgery. He is best known as a key architect of the Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection (IG-MIPR), a landmark 2019 publication with 478 citations that established the first international consensus on patient selection, technical standards, and outcomes for laparoscopic and robotic pancreatic resections. This guideline has become the definitive reference for surgeons worldwide. Dr. Senthilnathan’s research rigorously compares minimally invasive approaches to open surgery, as demonstrated by his 2023 individual patient data meta-analysis of randomized trials on pancreatoduodenectomy for pancreatic ductal adenocarcinoma (30 citations), which provides high-level evidence on oncologic equivalence and recovery benefits. His expertise also extends to colorectal liver metastasis management, where he has contributed to optimizing resection strategies. A prolific academic surgeon, Dr. Senthilnathan’s work bridges the gap between high-volume surgical practice and evidence-based guideline development, directly improving patient outcomes and training the next generation of HPB specialists.